Clinical Trial Detail

NCT ID NCT02473497
Title Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements yes
Sponsors Pfizer
Indications

Advanced Solid Tumor

Therapies

Crizotinib

Age Groups: child adult senior

Additional content available in CKB BOOST